This inventor holds 2 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 4 EPO patents. Top assignees: Serendia LLC, Viol Co. Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Jongju Na: Innovator in Medical Technology
Introduction
Jongju Na is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly through his innovative patents. With a total of 2 patents, Na has focused on developing advanced medical devices that enhance treatment methods.
Latest Patents
Jongju Na's latest patents include a needle assembly and a skin stimulator, along with a manufacturing method for the same. The needle assembly features a plurality of needles and a main body with multiple holes that allow the needles to pass in a first direction. Additionally, it includes a fixing member that has several fixed inclined surfaces to support the needles. Another notable invention is an apparatus for treating submucosal tissue, which consists of a probe capable of approaching the mucosa of a treatment field. This apparatus also includes an electrode that applies an electrical signal to the blood vessels of the submucosa, along with a guide that accommodates the probe and helps position the electrode accurately.
Career Highlights
Throughout his career, Jongju Na has worked with various companies, including Viol Co. Ltd. and Serendia LLC. His experience in these organizations has allowed him to refine his skills and contribute to the development of innovative medical technologies.
Collaborations
Some of his notable coworkers include Dongkeun Shin and Heeyoung Lee. Their collaboration has likely played a role in the successful development of his patents and innovations.
Conclusion
Jongju Na is a dedicated inventor whose work in medical technology has the potential to significantly impact treatment methods. His innovative patents reflect his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile